The Association Between Conditioned Pain Modulation and Pain Catastrophizing in Chronic Low Back Pain

NCT03644810 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2018-12-24

No results posted yet for this study

Summary

This study evaluates the potential association between pain catastrophizing thoughts and the ability to dampen pain via endogenous descending inhibition. Half of the participants are persons with chronic low back pain and the other half are age and gender-matched controls

Conditions

  • Catastrophizing Pain
  • Pain, Somatic
  • Chronic Low Back Pain

Interventions

DIAGNOSTIC_TEST

PPT measurement

The sensitivity to pressure which is gradually increased is assessed. The procedure is performed at the back and the lower leg

DIAGNOSTIC_TEST

Pain catastrophizing scale

A validated questionnaire that measures three domains of pain-related catastrophizing thoughts: helplessness, rumination and excessive magnification

PROCEDURE

Cold Pressor Test

The participant submerges one hand into a tank of cold (5 deg C), circulating water. The procedure is commonly know to decrease the sensitivity to pressure (PPT procedure) so that a difference appears in pain sensitivity when comparing PPT values before and after the procedure

Sponsors & Collaborators

  • Spine Centre of Southern Denmark

    collaborator OTHER
  • Aalborg University

    lead OTHER

Principal Investigators

  • Thorvaldur S Palsson, PhD · Aalborg University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2017-09-01
Completion
2018-11-08

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03644810 on ClinicalTrials.gov